ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
151 hedge funds and large institutions have $578M invested in Array Biopharma Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
44% less call options, than puts
Call options by funds: $6.85M | Put options by funds: $12.2M
Holders
151
Holding in Top 10
2
Calls
$6.85M
Puts
$12.2M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$9.63M | |
| 3 | +$8.39M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.46M |
| 5 |
TA
Teachers Advisors
New York
|
+$4.41M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$16.6M | |
| 3 | -$12.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$10.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.97M |